Drug Safety
The Food and Drug Administration (FDA) is charged with ensuring the safety of drugs in the U.S. The FDA plays the important role of approving drugs based on the results of clinical trials as well as monitoring and gathering data to ensure to determine if any adverse drugs reactions have become apparent after the drugs enter the marketplace. The FDA developed MedWatch to provide important safety information to consumers and to allow consumers to report serious problems with human medical products. For the best outcomes, consumers must be informed about this MedWatch system so that they can learn important safety information on the drugs that they take and how to report adverse reactions to prescription drugs. As part of the passage of the Food and Drug Safety Act of 2007, I worked to include a requirement that will improve consumers' awareness of the MedWatch Program. My amendment, which was incorporated into the law, requires that printed prescription drug ads include information on how to report side effects to the FDA's MedWatch program both on the internet and through a toll-free number. The FDA was also required to study how we can best include this important information in TV ads for prescription medications.
Resources
More on Drug Safety
Thanks to the Inflation Reduction Act, starting in January 2023, insulin will be capped at $35 per month for Medicare beneficiaries. If the Inflation Reduction Act's $35 insulin cap was in effect in 2020, a Medicare beneficiary in Illinois' 9th Congressional District enrolled in a Medicare plan could have saved $1,433 per year. This is a matter of life and death. I held a press conference last week to highlight this important provision. We heard from a constituent who said that he often must decide between paying his bills or getting his lifesaving medication.
WASHINGTON - Congresswoman Jan Schakowsky (D-IL), a Senior Chief Deputy Whip and Chair of the Consumer Protection and Commerce Subcommittee of the Energy and Commerce Committee, released the following statement today after the House of Representatives passed the Inflation Reduction Act:
WASHINGTON – Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and Chairwoman of Consumer Protection and Commerce Subcommittee of the House Energy and Commerce Committee, celebrated the House of Representatives' passage of the America COMPETES Act, a bold and transformative legislative package to supercharge American production of chips, strengthen U.S. supply chains and strengthen American manufacturing, advance U.S. scientific excellence and research and position American interest and values to win on the world stage.
Accessibility Standards
If you have any difficulty viewing any page with assistive technology or experience any issues accessing this website, please contact us so that we can improve this website. Please be as specific as possible in your description of the issue(s) encountered, as well as the location on the website.
In order to maximize accessibility, this website has been designed in conformance with:
H.R. 1319, The American Rescue Plan Act of 2021
An Urgently-Needed Package to Address The Coronavirus Health & Economic Crisis
Passed House of Representatives February 27, 2021
Amended and Passed by the Senate on March 6, 2021
Senate Changes Passed by House on March 10, 2021
WASHINGTON - Today, Congresswoman Jan Schakowsky, a Senior Chief Deputy Whip and a senior member of the House Budget Committee, released the following statement after the House of Representatives passed H.R. 1319, President Biden's American Rescue Plan Act, by a vote of 219-210:
